This inventor holds 2 USPTO granted patents. Top assignee: Merck Patent Gesellschaft MIT. Active years: 2002-2003.
Company Filing History:
Years Active: 2002-2003
Title: Thierry Holot: Innovator in Galenic Formulations
Introduction
Thierry Holot is a notable inventor based in Lyon, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of orally administrable galenic forms. With a total of 2 patents, his work focuses on enhancing the absorption of active ingredients in the gastrointestinal tract.
Latest Patents
Holot's latest patents include innovative formulations that improve the absorption of hydrophilic or ionizable active ingredients. One of his inventions is an orally administrable immediate-release and prolonged-release galenic form that comprises an absorption-promoting agent. This formulation allows for improved absorption through the transmembrane or paracellular route in the gastrointestinal tract. The galenic formulation includes at least one active ingredient, an absorption-promoting agent, and one or more pharmaceutically acceptable excipients. Another patent details a controlled-release tablet containing specific components such as calcium acamprosate and various excipients, designed to enhance the therapeutic efficacy of the active ingredients.
Career Highlights
Holot is associated with Merck Patent Gesellschaft MIT, where he continues to innovate in the field of pharmaceutical sciences. His work has been instrumental in developing formulations that address the challenges of drug absorption, thereby improving patient outcomes.
Collaborations
Throughout his career, Holot has collaborated with esteemed colleagues such as Olivier Saslawski and Philippe Giet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thierry Holot's contributions to the field of galenic formulations highlight his commitment to advancing pharmaceutical science. His innovative patents reflect a deep understanding of drug absorption mechanisms, making him a valuable asset in the industry.